SUO 2020 GU Malignancies Prostate

Viewing 1-20 of 30 articles

SUO 2020: The Future of Prostate Cancer Screening

SUO 2020: Clinical Trials of Focal Prostate Ablation

SUO 2020: Imaging of The Primary Tumor - Prostate Cancer

SUO 2020: Focal Therapy and Partial Gland Ablation for Prostate Cancer

SUO 2020: Use of Biomarkers to Select Patients for Active Surveillance and Focal Ablation

SUO 2020: An Update on Imaging of Primary Prostate Cancer

SUO 2020: Impact of PSMA Scans on Clinical Management-Point/Counterpoint

SUO 2020: 2020 EAU Lecture: PROBASE – The German Risk-Adapted Prostate Cancer Screening Trial – First Results

SUO 2020: The Impact of Systemic Racism on Urologic Cancer Care

SUO 2020: Understanding the Evolving Treatment Landscape of Metastatic Castration-Resistant Prostate Cancer: How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes

SUO 2020: Understanding the Evolving Treatment Landscape of Prostate Cancer (nmCRPC and mHSPC): How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes

SUO 2020: The Promising Role of PSMA-PET CT Scanning for Patients Diagnosed with Prostate Cancer

SUO 2020: Application of Deep Learning Detection and Grading System for Identification of Clinically Significant Prostate Cancer on Whole Mount Pathology

SUO 2020: Biomarker Review: Predictive/Actionable Biomarkers for Metastatic Prostate Cancer

SUO 2020: Transperineal Prostate Biopsy Update

SUO 2020: Non-Metastatic Castrate-Resistant Prostate Cancer - PROSPER Trial Update

SUO 2020: The Role of Prostate-Specific Membrane Antigen (PSMA) Scanning in Prostate Cancer (Up)Staging

SUO 2020: Radiogenomics: What are Prostate mpMRIs Telling Us?

SUO 2020: Impact of PSMA Scans on Clinical Management - PSMA PET-CT is Not Ready for Prime-Time Use

SUO 2020: Computer-Assisted Pathological Diagnosis

1
2